iRhythm Technologies, Inc. (IRTC)

188.98 +1.58 (+0.85%) USD  |  NASDAQ  |  Jan 08, 16:00
188.98 0.00 (0.00%) After-Hours: 20:00
More

iRhythm Technologies Research and Development Expense (Quarterly): 21.03M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for IRTC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Baxter International, Inc. 115.00M
Alphatec Holdings, Inc. 18.68M
AtriCure, Inc. 22.13M
Integra LifeSciences Holdings Corp. 20.42M
Tandem Diabetes Care, Inc. 47.88M